Regeneron Pharmaceuticals, Inc.

Form 483

New YorkFEI 3015581066Issued January 16, 2026

View FDA's Record for This Firm

Source: Third-party index, not matched to FDA. This record came from a third-party Form 483 index rather than from FDA directly, and we have not been able to match it to a document or an inspection FDA publishes. It stays out of the default view for that reason. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3015581066.

ObservationsNot available

Issue DateJanuary 16, 2026

StatusNo Warning Letter

Establishment TypeDrug Product Manufacturer

Related Inspections0

Establishment Details

Firm: Regeneron Pharmaceuticals, Inc.
Location: New York
FEI Number: 3015581066
Establishment Type: Drug Product Manufacturer
Issue Date: January 16, 2026
Country: United States

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Regeneron Pharmaceuticals, Inc. FDA Form 483, New York, January 16, 2026